Nomic Bio
Nomic Bio is a biotechnology company based in London, UK, that specializes in protein profiling. Founded in 2017, the company focuses on advancing the field of proteomics through its innovative nELISA platform. This next-generation immunoassay technology utilizes DNA nanotechnology to enhance traditional methods, enabling high-throughput analysis of proteins. The nELISA platform allows researchers to analyze over 275 proteins in a single assay, providing flexibility and efficiency. It supports the processing of more than 10,000 samples per week, ensuring accurate and cost-effective quantitative profiling. Nomic Bio's technology is particularly valuable in high-throughput drug discovery and inflammation research, facilitating the comprehensive profiling of secreted proteins essential for developing new treatments. Nomic Bio has attracted significant funding, including a $42 million Series B round in September 2024, and employs around 40 people. The company actively participates in major scientific events, showcasing its advancements in proteomics and is recognized for its innovative contributions to the field.
Work at Nomic Bio in HR or recruiting? Claim this page
Headcount trend
Nomic Bio went from 62 employees in Oct 2024 to 103 in Sep 2026. Apr to Sep 2026: 10 people joined, 0 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Sep 2024 | Series B | $42M | 5 | |
| Dec 2021 | Series A | $17M | 3 | |
| Jul 2020 | Funding | $1M | 1 |
Org structure
Headcount by department
Peer reviews
Worked with someone at Nomic Bio?
Anonymous peer reviews on OffTheRecord
Similar companies
Nomic Bio FAQ
How many employees does Nomic Bio have?
Nomic Bio has about 103 employees, down 1% over the 3 months to Sep 2026.
What is Nomic Bio's revenue per employee?
Nomic Bio makes about $19K in revenue per employee, based on $2M annual revenue and 103 employees.
How much funding has Nomic Bio raised?
Nomic Bio has raised $60M in total funding; its latest round was Series B in Sep 2024.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.